Julie Cooke - 02 Oct 2020 Form 4/A - Amendment Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Role
Chief Human Resources Officer
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
Issuer symbol
NBIX
Transactions as of
02 Oct 2020
Net transactions value
$0
Form type
4/A - Amendment
Filing time
03 May 2023, 17:20:43 UTC
Date Of Original Report
06 Oct 2020
Next filing
06 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NBIX Common Stock 9,554 02 Oct 2020 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The initial Form 4 filed on 10/06/2020 inadvertently omitted 5 shares that the reporting person owned directly associated with the purchase of such shares on August 31, 2020 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan